Aerosolized ACE2 neutralizes COVID-19 variants in lab and mice tests

Researchers from the University of Texas Southwestern have developed an aerosolized, mutated form of ACE2 that effectively neutralizes various SARS-CoV-2 variants in both cell cultures and mice. The study suggests that this modified ACE2 has promising preventive and therapeutic potential against COVID-19, especially with its easy aerosolized administration.

Related Keywords

United States ,Susha Cheriyedath ,University Of Texas Southwestern ,Texas Southwestern ,Ace2 ,Coronavirus Disease Covid 19 ,Ngiotensin ,Ngiotensin Converting Enzyme 2 ,Fell ,Coronavirus ,Drug Discovery ,Efficacy ,Nzyme ,Immune System ,N Vitro ,N Vivo ,Lentivirus ,Utation ,Protein ,Eceptor ,Research ,Espiratory ,Cars ,Ars Cov 2 ,Evere Acute Respiratory ,Evere Acute Respiratory Syndrome ,Yndrome ,Virus ,